MetaCap

Actinium Pharmaceuticals (Delaware) (ATNM) vs MindWalk (HYFT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Actinium Pharmaceuticals (Delaware) (ATNM) has outperformed MindWalk (HYFT) over the past year, losing 21.1% versus a loss of 59.0%. Over five years, ATNM leads with a -85.6% price change compared with -89.3% for HYFT. Actinium Pharmaceuticals (Delaware) is the larger company by market cap ($33.0 million vs $32.6 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ATNM-21.05%HYFT-59.02%
+73%+4%-65%
Nov 21, 20251 yearNov 20, 2026
ATNM-86.22%HYFT-87.65%
+79%-12%-102%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ATNM versus HYFT key metrics
MetricATNMHYFT
Share price$1.05$0.6844
Market cap$33.01M$32.56M
1-day change-1.87%-14.27%
YTD return-22.79%-62.40%
1-year return-21.05%-59.02%
5-year return-85.60%-89.34%
P/E ratio (TTM)2.44—
EPS (TTM)$0.43$-0.26
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$90.00K—
Net income (latest FY)$-33.89M—
Operating margin-40274.44%—
Net margin-37652.22%—
52-week high$1.72$2.99
52-week low$0.735$0.64
Distance from 52-week high-38.95%-77.11%
Analyst consensusnonenone
Avg. price target upside+242.86%+532.67%
Average volume193.83K257.86K
Shares outstanding31.44M47.57M
Employees2774
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ATNM has outperformed HYFT by 38.0 percentage points over the past year.

About Actinium Pharmaceuticals (Delaware)

ATNM stock →

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies.

Health Care · Biotechnology: Pharmaceutical Preparations · 27 employees

About MindWalk

HYFT stock →

MindWalk Holdings Corp. operates as a bio-native AI company.

Health Care · Biotechnology: Pharmaceutical Preparations · 74 employees

ATNM vs HYFT FAQ

Which is bigger, Actinium Pharmaceuticals (Delaware) or MindWalk?

Actinium Pharmaceuticals (Delaware) (ATNM) is larger, with a market capitalization of $33.01M compared with $32.56M for MindWalk (HYFT).

Which stock has performed better over the past year, ATNM or HYFT?

ATNM returned -21.05% over the past 12 months, compared with -59.02% for HYFT (price return, excluding dividends). Past performance does not predict future results.

Are Actinium Pharmaceuticals (Delaware) and MindWalk in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons